Roberts Glore & CO Inc Vertex Pharmaceuticals Inc Transaction History
Roberts Glore & CO Inc
- $330 Million
- Q1 2024
A detailed history of Roberts Glore & CO Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Roberts Glore & CO Inc holds 4,585 shares of VRTX stock, worth $2.27 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
4,585
Previous 4,857
5.6%
Holding current value
$2.27 Million
Previous $1.98 Million
3.04%
% of portfolio
0.58%
Previous 0.62%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,651Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.7 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$11.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.9 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.95 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.51 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $127B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...